Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1)

Journal of Experimental Medicine

Volumn 186, Issue 2, 1997, Pages 313-323

  Yuan, Qian ^a,b   Frank Austen, K ^a,b   Friend, Daniel S ^a,b   Heidtman, Matthew ^b   Boyce, Joshua A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; EOSINOPHIL; FLUOROGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

CELL ADHESION; CHEMOKINES, CC; CYTOKINES; EOSINOPHILS; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4BETA1; INTEGRINS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, LYMPHOCYTE HOMING; RECOMBINANT PROTEINS; STEM CELL FACTOR; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1842292721     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.2.313     Document Type: Article

References (76)

1. Resnick, M.B., and P.F. Weller. 1993. Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8:349-355.
2. Spry, C.J. 1971. Mechanisms of eosinophilia. V. Kinetics of normal and accelerated eosinopoiesis. Cell Tissue Kin. 4:351-364.
3. Butterworth, A.E., R.F. Sturrock, V. Houba, and P.H. Rees. 1974. Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature (Lond.). 252:503-505.
4. Kipnis, T.L., S.L. James, A. Sher, and J.R. David. 1981. Cell-mediated cytotoxicity by Trypanosoma cruzi. II. Antibody-dependent killing of bloodstream forms by mouse eosinophils and neutrophils. Am. J. Trop. Med. Hyg. 30:47-53.
5. Folkard, S.G., P.J. Hogarth, M.J. Taylor, and A.E. Bianco. 1996. Eosinophils are the major effector cells of immunity to microfilariae in a mouse model of onchocerciasis. Parasitology. 112:323-329.
6. Rotman, H.L., W. Yutanawiboonchai, R.A. Brigandi, O. Leon, G.J. Gleich, T.J. Nolan, G.A. Schad, and D. Abraham. 1996. Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp. Parasitol. 82:267-278.
7. Enblad, G., C. Sundstrom, and B. Glimelius. 1993. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol. Oncol. 11:187-193.
8. Ownby, H.E., L.D. Roi, R.R. Isenberg, and M.J. Brennan. 1983. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer. 52:126-130.
9. Rivoltini, L., V. Viggiano, S. Spinazze, A. Santoro, M.P. Colombo, K. Takatsu, and G. Parmiani. 1993. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Int. J. Cancer. 54:8-15.
10. Todd, R., B.R. Donoff, T. Chiang, M.Y. Chou, A. Elovic, G.T. Gallagher, and D.T. Wong. 1991. The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am. J. Pathol. 138:1307-1313.
11. Wong, D.T., R.B. Donoff, J. Yang, S.Z. Song, K. Matossian, N. Nagura, A. Elovic, J. McBride, G. Gallagher, R. Todd et al. 1993. Sequential expression of transforming growth factors α and β 1 by eosinophils during cutaneous wound healing in the hamster. Am. J. Pathol. 143:130-142.
12. Frigas, E., D.A. Loergering, and G.J. Gleich. 1980. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab. Invest. 42:35-43.
13. 4 by human eosinophils. J. Immunol. 138: 532-538.
14. Bentley, A.M., G. Menz, C. Storz, D.S. Robinson, B. Bradley, P.K. Jeffery, S.R. Durham, and A.B. Kay. 1992. Identification of T lymphocytes, macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial hyperresponsiveness. Am. Rev. Respir. Dis. 146:500-506.
15. Walsh, G.M., M.L. Williamson, F.A. Symon, G.B. Willars, and A.J. Wardlaw. 1996. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood. 87:2815-2821.
16. Rothenberg, M.E., J. Petersen, R.L. Stevens, D.S. Silberstein, D.T. McKenzie, K.F. Austen, and W.F. Owen. 1989. IL-5-dependent conversion of normodense eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J. Immunol. 143:2311-2316.
17. Owen, W.F., M.E. Rothenberg, D.S. Silberstein, J.C. Gasson, R.L. Stevens, K.F. Austen, and R.J. Soberman. 1987. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166:129-141.
18. Bochner, B.S., F.W. Luscinaskas, M.A. Gimbrone, Jr., W. Newman, S.A. Sterbinsky, C.P. Derse-Anthony, D. Klunk, and R.P. Schleimer. 1991. Adhesion of human basophils and eosinophils to IL-1 activated human vascular endothelial cells: contribution of endothelial cell adhesion molecules. J. Exp. Med. 173:1553-1557.
19. Erle, D.J., M.J. Briskin, E.C. Butcher, A. Garcia-Pardo, A.I. Lazarovits, and M. Tidswell. 1994. Expression and function of the MAdCAM-1 receptor, integrin α4β7, on human leukocytes. J. Immunol. 153:517-528.
20. Georas, S.N., B.W. McIntyre, M. Ebisawa, J.L. Bednarczyk, S.A. Sterbinsky, R.P. Schleimer, and B.S. Bochner. 1993. Expression of a functional laminin receptor α6β1 (very late antigen 6) on human eosinophils. Blood. 82:2872-2879.
21. Elices, M.J., L. Osborn, Y. Takada, C. Crouse, S. Lubowsky, M.E. Hemler, and R.R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:577-584.
22. Lobb, R.R., and M.E. Hemler. 1994. The pathophysiologic role of α4 integrins in vivo. J. Clin. Invest. 94:1722-1728.
23. Weg, V.B., T.J. Williams, R.R. Lobb, and S. Nourshargh. 1993. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J. Exp. Med. 177:561-566.
24. Nakajima, H., H. Sano, T. Nishimura, S. Yoshida, and I. Iwamoto. 1994. Role of vascular cell adhesion molecule 1/ very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into tissue. J. Exp. Med. 179:1145-1154.
25. Pretolani, M.C., C. Ruffie, J.-R. Lapa e Silva, D. Joseph, R.R. Lobb, and B. Vargaftig. 1994. Antibody against very late antigen-4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in guinea-pig airways. J. Exp. Med. 180:795-805.
26. Abraham, W.M., M.W. Sielczak, A. Ahmed, A. Cortes, I.T. Lauredo, J. Kim, B. Pepinsky, C.D. Benjamin, D.R. Leone, R.R. Lobb, and P.F. Weller. 1994. α4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J. Clin. Invest. 93:776-787.
27. Guan, J.L., and R.O. Hynes. 1990. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell. 60:53-61.
28. Anwar, A.R.F., R. Moqbel, G.M. Walsh, A.B. Kay, and A.J. Wardlaw. 1993. Adhesion to fibronectin prolongs eosinophil survival. J. Exp. Med. 177:839-843.
29. Ohno, I., R. Lea, S. Finotto, J. Marshall, J. Denburg, J. Dolovich, J. Gauldie, and M. Jordana. 1991. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am. J. Respir. Cell Mol. Biol. 5:505-510.
30. Broide, D.H., M. Paine, and G.S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte-macrophage colony-stimulating factor mRNA at sites of allergic inflammation. J. Clin. Invest. 90:1414-1424.
31. Russell, E.S. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20:357-459.
32. Kitamura, Y. 1989. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7:59-76.
33. 41 and W. EMBO (Eur. Mol. Biol. Organ.) J. 9:1805-1813.
34. Zsebo, K.M., D.A. Williams, E.N. Geissler, V.C. Broudy, F.H. Martin, H.L. Atkins, R.-Y. Hsu, N.C. Birkett, K.H. Okino, D.C. Murdock et al. 1990. Stem cell factor is encoded at the sl locus of the mouse and is the ligand for the c-kit tyrosine receptor. Cell. 63:213-224.
35. Anderson, D.M., S.D. Lyman, A. Baird, J.M. Wignall, J. Eisenman, C. Rauch, C.J. March, H.S. Boswell, S.D. Gimpel, D. Cosman, and S.E. Williams. 1990. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane and soluble forms. Cell. 63:235-243.
36. Langley, K.E., L.G. Bennet, J. Wypych, S.A. Yancik, X.-D. Liu, K.R. Westcott, D.G. Chang, K.A. Smith, and K.M. Zsebo. 1993. Soluble stem cell factor in human serum. Blood. 81:656-660.
37. Heinrich, M.C., D.C. Dooley, A.C. Freed, L. Band, M.E. Hoatlin, W.W. Keeble, S.T. Peters, K.S. Silvey, F.S. Ey, D. Kabat, R.T. Maziarz, and G.C. Bagby, Jr. 1993. Constitutive expression of steel factor gene by human stromal cells. Blood. 82:771-783.
38. Ogawa, M., Y. Matsuzaki, S. Nishikawa, S.-I. Hayashi, T. Kunisada, T. Sudo, T. Kina, H. Nakauchi, and S.-I. Nishikawa. 1991. Expression and function of c-kit in hemopoietic progenitor cells. J. Exp. Med. 174:63-71.
39. Copeland, N.G., D.J. Gilbert, B.C. Cho, P.J. Donovan, N.A. Jenkins, D. Cosman, D. Anderson, S.D. Lyman, and D.E. Williams. 1990. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell. 63:175-183.
40. Tsai, M., T. Takeishi, H. Thompson, K.E. Langley, K.M. Zsebo, D.D. Metcalfe, E.N. Geissler, and S.J. Galli. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA. 88:6382-6386.
41. 4 synthase pathway in mouse mast cells. J. Biol. Chem. 270:22653-22656.
42. Tsuji, K., K. Koike, A. Komiyama, A. Miyajima, K. Arai, and T. Nakahata. 1995. Synergistic action of interleukin-10 (IL-10) with IL-3, IL-4 and stem cell factor on colony formation from murine mast cells in culture. Int. J. Hematol. 61:51-60.
43. 2 from cord blood mononuclear cells. J. Immunol. 157:343-350.
44. Mitsui, H., T. Furitsu, A.M. Dvorak, A.M.A. Irani, L.B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K.M. Zsebo, S. Gills, and T. Ishizaka. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl. Acad. Sci. USA. 90:735-739.
45. Bischoff, S.C., and C.A. Dahinden. 1992. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175:237-244.
46. Okayama, Y., C. Petit-Frere, O. Kassel, A. Semper, D. Quint, M.J. Tunon-de-Lara, P. Bradding, S.T. Holgate, and M.K. Church. 1995. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J. Immunol. 155: 1796-1808.
47. Murakami, M., R. Matsumoto, Y. Urade, K.F. Austen, and J.P. Arm. 1995. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxidase synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J. Biol. Chem. 270:3239-3246.
48. Murakami, M., K.F. Austen, and J.P. Arm. 1995. The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. J. Exp. Med. 182:197-206.
49. Dastych, J., and D.D. Metcalfe. 1994. Stem cell factor induces mast cell adhesion to fibronectin. J. Immunol. 152:213-219.
50. Kinashi, T., and T.A. Springer. 1994. Steel factor and c-kit regulate cell-matrix adhesion. Blood. 83:1033-1038.
51. Kinashi, T., J.A. Escobedo, L.T. Williams, K. Takatsu, and T.A. Springer. 1995. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-γ1 pathways. Blood. 86:2086-2090.
52. Yuan, Q., K.L. Strauch, R.R. Lobb, and M.E. Hemler. 1996. Intracellular single-chain antibody inhibits integrin VLA-4 maturation and function. Biochem. J. 318:591-596.
53. Hemler, M.E., C. Huang, Y. Takada, L. Schwartz, J.L. Strominger, and M.L. Clabby. 1987. Characterization of the cell surface heterodimer VLA-4 and related peptides. J. Biol. Chem. 262:11478-11485.
54. Kennel, S.J., R.G. Epler, T.K. Lankford, L.T. Foote, V. Dickas, M. Canamucio, R. Cavalierie, M. Cosimelli, I. Venturo, R. Falcioni, and A. Sacchi. 1990. Second generation monoclonal antibodies to the human integrin α6β4. Hybridoma. 9: 243-255.
55. Hemler, M.E., C.F. Ware, and J.L. Strominger. 1983. Characterization of a novel differentiation antigen complex recognized by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells. J. Immunol. 131:334-340.
56. Lazarovits, A.I., R.A. Moscicki, J.T. Kurnick, D. Camerini, A.K. Bhan, L.G. Baird, M. Erikson, and R.B. Colvin. 1984. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. J. Immunol. 133:1857-1862.
57. Lemke, H., G.J. Hammerling, C. Hohmann, and K. Rajewsky. 1978. Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse Nature (Lond.). 271:249-251.
58. Broudy, V.C., N. Lin, K.M. Zsebo, N.C. Birkett, K.A. Smith, I.D. Bernstein, and T. Papayannopoulou. 1992. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood. 79:338-346.
59. Hansel, T.T., I.J. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods. 145:105-110.
60. Buhring, H.-J., L.K. Ashman, V. Gattei, B. Kniep, A. Larregina, A. Pinto, P. Valent, and J.J. van den Oord. 1995. Stem-cell factor receptor (p1459 (c-kit)) summary report (CD117). In Leucocyte Typing V: White Cell Differentiation Antigens. S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.F. Tedder, and R.F. Todd, editors. Oxford University Press, Oxford. 1882-1888.
61. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of airways inflammation. J. Exp. Med. 179:881-887.
62. Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.A. Gonzalo, W. Newman et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
63. Weber, C., J. Kitayama, and T.A. Springer. 1996. Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils. Proc. Natl. Acad. Sci. USA. 93:10939-10944.
64. Columbo, M., E.M., Horowitz, L.M. Botana, D.W. MacGlashan, Jr., B.S. Bochner, S. Gillis, K.M. Zsebo, S.J. Galli, and L.M. Lichtenstein. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149:599-608.
65. Boyce, J.A., D. Friend, R. Matsumoto, K.F. Austen, and W.F. Owen. 1995. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J. Exp. Med. 182:49-57.
66. Kovach, N.L., N. Lin, T. Yednock, J.M. Harlan, and V.C. Broudy. 1995. Stem cell factor modulates avidity of α4β1 and α5β1 integrins expressed on hematopoietic cell lines. Blood. 85:159-167.
67. Lauffenburger, D.A. 1991. Models for receptor-mediated cell phenomena: adhesion and migration. Annu. Rev. Biophys. Biophys. Chem. 20:387-414.
68. Diaz-Gonzalez, F., J. Forsyth, B. Steiner, and M.H. Ginsberg. 1996. Transdominant inhibition of integrin function. Mol. Biol. Cell. 7:1939-1951.
69. Hughes, P.E., M.W. Renshaw, M. Pfaff, J. Forsyth, V.M. Keivens, M.A. Schwartz, and M.H. Ginsberg. 1997. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell. 88:521-530.
70. Lukacs, N.W., R.M. Stricter, P.M. Lincoln, E. Brownell, D.M. Pullen, H.J. Schock, S.W. Chensue, D.D. Taub, and S.L. Kunkel. 1996. Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. J. Immunol. 156:3945-3951.
71. Bevilacqua, M.P. 1993. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767-804.
72. Palecek, S.P., J.C. Loftus, M.H. Ginsberg, D.A. Lauffenburger, and A.f. Horwitz. 1997. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature (Lond.). 385:537-540.
73. Bentley, A.M., S.R. Durham, D.S. Robinson, G. Menz, C. Storz, O. Cromwell, A.B. Kay, and A.J. Wardlaw. 1993. Expression of endothelial cell and leukocyte adhesion molecules, intercellular adhesion molecule-1, E-selectin and vascular cell adhesion molecule-1 in the bronchial mucosa in steady state and allergen-induced asthma. J. Allergy. Clin. Immunol. 92:857-868.
74. Ohkawara Y., K. Yamauchi, N. Maruyama, H. Hoshi, I. Ohno, M. Honma, Y. Tanno, G. Tamura, K. Shirato, and H. Ohtani. 1995. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 12:4-12.
75. Bradding, P., J.A. Roberts, K.M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C.H. Heusser, P.H. Howarth, and S.T. Holgate. 1994. Interleukin-4, interleukin-5, and interleukin-6 and tumor necrosis factor-α in normal and asthmatic airways - evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-480.
76. Iademarco, M.F., J.L. Barks, and D.C. Dean. 1995. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J. Clin. Invest. 95: 264-271.